Crinetics Pharmaceuticals Inc (CRNX)

NASDAQ · Pharmaceuticals

84.76
+0.04 (+0.05%)
Updated Aug 19, 5:45 PM ET
AI Rating
Buy
Overall Score
64
Trend
75
Momentum
31
Risk
92

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Crinetics Pharmaceuticals Inc is trading at $84.76, up 0.05% on the session. The 50 day average sits at $63.78 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 90.5, which reads as overbought, and MACD is bearish crossover. Volume is below average.

The nearest support is around $83.64 with resistance near $84.71, so that band frames the current range. Average daily movement is roughly $0.82, or about 1.0% of the share price, which is what any stop placement has to allow for. The overall health score of 64 out of 100 combines a trend score of 75, momentum of 31 and a risk score of 92.

Technical indicators

RSI (14)
90.5
overbought
MACD
4.856
bearish crossover
SMA 20
83.97
SMA 50
63.78
SMA 200
--
unknown
ATR (14)
0.82
avg daily range
Support
83.64
Resistance
84.71
Volume vs 20d
0.82x
below average
Volatility
2.5%
annualised
1 month
+0.94%
3 months
+121.09%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.